Digital Health Investors & VC Firms in Asia-Pacific
133 firms in this list, with a median first check of $696K. 25 of them lead rounds. Generated from verified public data and updated continuously.
V3 Ventures
LondonPre-Seed–Series A$1M – $5M
13 people
Lilly Asia Ventures
Hong KongPre-Seed–Late Stage
1 person
Fast Track Initiative
TokyoPre-Seed–Growth$1.2M – $184M
2 people
MedTech Actuator
Seed–Series B
Goodwater Capital
BurlingamePre-Seed–Late Stage$5M – $50M
10 people
Pix Vine Capital
SingaporeSeed–Series A$250K – $500K
1 person
Mobility Ventures
AddisonSeed–Series A
23 people
Bailador Technology Investments
SydneyGrowth$3.3M – $13.2M
12 people
LYFE Capital
Menlo ParkSeed–Late Stage
17 people
Minerva Growth Partners
TokyoGrowth–Late Stage$6.7M – $20M
14 people
VentureWave Capital Ltd.
DublinSeed–Series B
21 people
Kinled Holding
Hong KongSeed–Series A
1 person
Planet N Group of Companies
LondonSeed
1 person
H.I.G. HealthBridge Partners
MiamiGrowth$5M – $40M
9 people
Brookstreet Equity Partners
LondonPre-Seed–Growth
20 people
Rebright Partners
TokyoPre-Seed–Series A
11 people
Maxpro Ventures
TaipeiSeed–Late Stage$10M – $13M
7 people
Emmeline Ventures
Paradise ValleyPre-Seed–Seed$50K – $500K
6 people
MDI Ventures
JakartaPre-Seed–Growth$500K – $75M
11 people
Apex Innovative Investments Ventures
VancouverPre-Seed–Series A$250K
9 people
Living Lab Ventures
TangerangPre-Seed–Series A$400K – $250M
7 people
Krungsri Finnovate
BangkokSeed–Late Stage
17 people
AI Angel Club
SeoulPre-Seed–Series A$74K – $4.8M
Japan startup support Association
OsakaPre-Seed–Growth
Related lists
Investors & VC Firms in United States (5050)Crypto & Web3 Investors & VC Firms (4688)Investors & VC Firms in Global (4044)SaaS Investors & VC Firms (3602)AI & Machine Learning Investors & VC Firms (3577)Fintech Investors & VC Firms (3506)Healthtech Investors & VC Firms (3208)Enterprise Software Investors & VC Firms (3098)Investors & VC Firms in Europe (2833)Consumer Investors & VC Firms (2381)
Data sourced from public filings and firms' own websites — see our methodology.






















































